# Study of DA-9501 In Pediatric Subjects In The Intensive Care Unit

> **NCT02757625** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 63 (actual)

## Conditions studied

- ICU Sedation

## Interventions

- **DRUG:** Dexmedetomidine hydrochloride

## Key facts

- **NCT ID:** NCT02757625
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-20
- **Primary completion:** 2017-05-24
- **Final completion:** 2017-05-24
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2018-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02757625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02757625, "Study of DA-9501 In Pediatric Subjects In The Intensive Care Unit". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02757625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*